Novo Integrated Sciences Inc (NVOS)

NASDAQ
Currency in USD
Disclaimer
0.128
+0.010
(+8.63%)
Closed
0.129
+0.001
(+1.016%)
After Hours
Delayed Data
Day's Range
0.110
0.137
52 wk Range
0.100
2.550
Volume
28,172,357
Prev. Close
0.118
Open
0.115
Day's Range
0.11-0.137
52 wk Range
0.1-2.55
Volume
28,172,357
Average Volume (3m)
28,030,953
1-Year Change
-94.43%
Shares Outstanding
144,257,518
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More

People Also Watch

0.243
BOXD
-29.39%

Novo Integrated Sciences Inc News

Novo Integrated Sciences Inc Company Profile

Novo Integrated Sciences, Inc. is a parent company to subsidiaries throughout North America. The Company owns Canadian and United States subsidiaries which provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The Company operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy (including pre- and post-partum), acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. The Company's products include ProDip and Terragenx.